Heart Attack Resource Center .: GluvSnap.com

Heart Attack News

FDA Approves New Indication for Crestor (Rosuvastatin)

Dec 31 - On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it. The new indication is for reduci... Read more »

Researchers Develop Innovative Imaging System to Study Sudden Cardiac Arrest

Feb 9 - A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arr... Read more »

FDA Approves Effient to Reduce the Risk of Heart Attack in Angioplasty Patients

Oct 31 - The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery. Read more »

Scientists Map Genetic Regulatory Elements for the Heart

Jul 13 - Scientists have devised a new computational model that can be used to reveal genetic regulatory elements responsible for development of the human heart and maintenance of its function. Although the teams focused on the heart, the computational me... Read more »

Heart Disease Awareness on the Rise But Prevention Still Critically Important for Women

Feb 22 - In recognition of American Heart Month, the National Heart, Lung, and Blood Institute (NHLBI) and its heart disease awareness campaign - The Heart Truth - is reminding all American women that heart disease prevention remains critically important, ... Read more »

FDA Approves Left Ventricular Assist System for Severe Heart Failure Patients

Feb 8 - The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. Read more »

FDA Warning on Plavix: Avoid Use with Prilosec/Prilosec OTC

Jan 20 - Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17. New data suggest that when patients take both Prilo... Read more »

Get More Heart Attack News >